DJIA 17,098.45 18.88 0.11%
NASDAQ 4,580.27 22.58 0.50%
S&P 500 2,003.37 6.63 0.33%
market minute promo

2.60 0.04 (1.56%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

RIGL $2.60 1.56%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.56
Previous Close $2.56
Daily Range $2.54 - $2.66
52-Week Range $2.31 - $5.00
Market Cap $228.3M
P/E Ratio -2.53
Dividend (Yield) $0.00 (0.0%)
Volume 911,753
Average Daily Volume 399,016
Current FY EPS -$1.12

Sector

Healthcare

Industry

Drugs

Rigel Pharmaceuticals, Inc. (RIGL) Description

The Company is a clinical-stage drug development company that discovers and develops novel, small molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. Website: http://www.rigel.com/

News & Commentary

Why VAALCO Energy, Rigel Pharmaceuticals, and Companhia Siderurgica Nacional Are Today's 3 Best Stoc

The S&P 500 dips for a second-straight day following weak economic data while VAALCO Energy, Rigel, and Companhia Siderurgica Nacional shares surge by double-digits.

What You Need to Know About the Roche-InterMune Deal

InterMune's Roche Deal Sends Peer Group Up

Rigel's R348 Fails in Phase II Study, Shares Down 13.6% - Analyst Blog

Why Rigel Pharmaceuticals (RIGL) Stock Is Declining Today

Sector Update: Health Cares Stocks Posting Strong Gains; Rigel Pharma Sinks After Scrapping Eye Drug

Sector Update: Health Cares Stocks Posting Strong Gains; Rigel Pharma Sinks After Scrapping Eye Drug Trial

Sector Update: Health Care

Rigel Pharmaceuticals Starts Fostamatinib Late Stage Program - Analyst Blog

Rigel Initiates Phase 3 Studies Of Fostamatinib In ITP

Is Rigel Pharmaceuticals (RIGL) Stock a Solid Choice Right Now? - Tale of the Tape

Is Rigel Pharmaceuticals (RIGL) Stock a Solid Choice Right Now? - Tale of the Tape

See More RIGL News...

RIGL's Top Competitors

RIGL $2.60 (1.56%)
Current stock: RIGL
AMGN $139.38 (0.50%)
Current stock: AMGN
GILD $107.56 (0.05%)
Current stock: GILD
BIIB $343.04 (0.53%)
Current stock: BIIB